NRA-AMLODIPINE 5MG: Affected lot may contain tablet(s) of Metoprolol Succinate prolonged–release 12.5 mg tablets
Brand(s)
Last updated
Summary
Product
NRA-AMLODIPINE 5MG
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Distribution
National
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot number |
|---|---|---|---|---|---|
| NORA PHARMA INC | NRA-AMLODIPINE 5MG | DIN 02476460 | Tablet | AMLODIPINE BESYLATE 5mg | EM240229 |
Issue
Affected lot may contain tablet(s) of Metoprolol Succinate prolonged–release 12.5 mg tablets
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Related recalls and alerts
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Nora Pharma Inc.
1565 Lionel-Boulet Blvd.
Varennes, QC
J3X 1P7
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type I
Identification number
RA-77705
Get notified
Receive emails about new and updated recall and safety alerts.